Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2015:2015:370451.
doi: 10.1155/2015/370451. Epub 2015 Feb 10.

Impact of ischemic preconditioning on outcome in clinical liver surgery: a systematic review

Michael J J Chu  1 , Ryash Vather  1 , Anthony J R Hickey  2 , Anthony R J Phillips  3 , Adam S J R Bartlett  4
Affiliations

Impact of ischemic preconditioning on outcome in clinical liver surgery: a systematic review

Michael J J Chu et al. Biomed Res Int. 2015.

Abstract

Background: Ischemia-reperfusion injury is a major cause of post-liver-surgery complications. Ischemic preconditioning (IPC) has been demonstrated to protect against ischemia-reperfusion injury. Clinical studies have examined IPC in liver surgery but with conflicting results. This systematic review aimed to evaluate the effects of IPC on outcome in clinical liver surgery.

Methods: An electronic search of OVID Medline and Embase databases was performed to identify studies that reported outcomes in patients undergoing liver surgery subjected to IPC. Basic descriptive statistics were used to summarise data from individual clinical studies.

Results: 1093 articles were identified, of which 24 met the inclusion criteria. Seven topics were selected and analysed by subgroup. There were 10 studies in cadaveric liver transplantation, 2 in living-related liver transplantation, and 12 in liver resection. IPC decreases hepatocellular damage in liver surgery as determined by transaminases but does not translate to any significant clinical benefit in orthotopic liver transplant or liver resection.

Conclusions: Available clinical evidence does not support routine use of IPC in liver surgery as it does not offer any apparent benefit in perioperative outcome. Further clinical studies will need to be carried out to determine the subset of patients that will benefit from IPC.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Quorum diagram.
See this image and copyright information in PMC

Similar articles

See all similar articles

Cited by

See all "Cited by" articles

References

    1. Jaeschke H. Mechanisms of reperfusion injury after warm ischemia of the liver. Journal of Hepato-Biliary-Pancreatic Surgery. 1998;5(4):402–408. doi: 10.1007/s005340050064. - DOI - PubMed
    1. Fondevila C., Busuttil R. W., Kupiec-Weglinski J. W. Hepatic ischemia/reperfusion injury—a fresh look. Experimental and Molecular Pathology. 2003;74(2):86–93. doi: 10.1016/s0014-4800(03)00008-x. - DOI - PubMed
    1. de Rougemont O., Dutkowski P., Clavien P.-A. Biological modulation of liver ischemia-reperfusion injury. Current Opinion in Organ Transplantation. 2010;15(2):183–189. doi: 10.1097/mot.0b013e3283373ced. - DOI - PubMed
    1. Selzner M., Clavien P.-A. Fatty liver in liver transplantation and surgery. Seminars in Liver Disease. 2001;21(1):105–113. doi: 10.1055/s-2001-12933. - DOI - PubMed
    1. Veteläinen R., van Vliet A., Gouma D. J., van Gulik T. M. Steatosis as a risk factor in liver surgery. Annals of Surgery. 2007;245(1):20–30. doi: 10.1097/01.sla.0000225113.88433.cf. - DOI - PMC - PubMed

Publication types

LinkOut - more resources